<DOC>
	<DOC>NCT01238783</DOC>
	<brief_summary>To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis</brief_summary>
	<brief_title>Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<criteria>Male and female patients of any race 5 years of age and older at the time of the Day 1 visit with a primary clinical diagnosis of bacterial conjunctivitis. Onset of bacterial conjunctivitis (signs and symptoms) more than 4 days Presence of punctal plug or punctal occlusion Visual Acuity worse than 20/80 Upper respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>